For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The price of Beam Therapeutics Inc (NASDAQ: BEAM) closed at $15.47 in the last session, up 5.74% from day before closing price of $14.63. In other words, the price has increased by $5.74 from its previous closing price. On the day, 2.38 million shares were traded. BEAM stock price reached its highest trading level at $15.665 during the session, while it also had its lowest trading level at $14.55.
Ratios:
We take a closer look at BEAM’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 4.82 and its Current Ratio is at 4.82. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.20.
On March 10, 2025, Scotiabank Upgraded its rating to Sector Outperform which previously was Sector Perform but kept the price unchanged to $40.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Apr 01 ’25 when Bellon Christine sold 5,674 shares for $18.35 per share. The transaction valued at 104,122 led to the insider holds 117,294 shares of the business.
Evans John M. sold 30,663 shares of BEAM for $562,684 on Apr 01 ’25. The CEO now owns 986,249 shares after completing the transaction at $18.35 per share. On Apr 01 ’25, another insider, Ciaramella Giuseppe, who serves as the President of the company, sold 7,434 shares for $18.35 each. As a result, the insider received 136,418 and left with 190,216 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BEAM now has a Market Capitalization of 1544524800 and an Enterprise Value of 565478976. For the stock, the TTM Price-to-Sale (P/S) ratio is 24.32 while its Price-to-Book (P/B) ratio in mrq is 1.76. Its current Enterprise Value per Revenue stands at 8.903 whereas that against EBITDA is -1.437.
Stock Price History:
The Beta on a monthly basis for BEAM is 2.41, which has changed by -0.39805448 over the last 52 weeks, in comparison to a change of 0.059571505 over the same period for the S&P500. Over the past 52 weeks, BEAM has reached a high of $35.25, while it has fallen to a 52-week low of $13.52. The 50-Day Moving Average of the stock is -37.25%, while the 200-Day Moving Average is calculated to be -39.03%.
Shares Statistics:
According to the various share statistics, BEAM traded on average about 2.04M shares per day over the past 3-months and 3975180 shares per day over the past 10 days. A total of 99.84M shares are outstanding, with a floating share count of 87.89M. Insiders hold about 11.97% of the company’s shares, while institutions hold 69.87% stake in the company. Shares short for BEAM as of 1743379200 were 14739307 with a Short Ratio of 7.23, compared to 1740700800 on 9992985. Therefore, it implies a Short% of Shares Outstanding of 14739307 and a Short% of Float of 18.34.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
